Glucocorticosteroids
Showing 1 - 25 of 121
Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA
Active, not recruiting
- GCA
- +3 more
- Tocilizumab 162Mg/0.9Ml Autoinjector
-
Reggio Emilia, Emilia Romagna, ItalyAusl-Irccs - S.C. Di Reumatologia
May 26, 2022
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Asthma Trial (SCH 32088 mometasone furoate (MF) metered-dose inhaler, Placebo metered-dose inhaler BID)
Withdrawn
- Asthma
- SCH 32088 mometasone furoate (MF) metered-dose inhaler
- Placebo metered-dose inhaler BID
- (no location specified)
Feb 7, 2022
Asthma Trial (mometasone furoate combination MDI 200/10 mcg BID, mometasone furoate combination MDI 400/10 mcg BID,
Completed
- Asthma
- mometasone furoate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Asthma Trial (Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI))
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) combination
- Mometasone furoate MDI (MF MDI)
- (no location specified)
Feb 7, 2022
Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol
Completed
- Asthma
- Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,
Completed
- Asthma
- mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)
Terminated
- Pulmonary Disease, Chronic Obstructive
- Bronchodilator Agents
-
Bari, BA, Italy
- +38 more
Dec 23, 2022
COVID-19 Pneumonia Trial (Low-Dose Radiation Therapy)
Not yet recruiting
- COVID-19 Pneumonia
- Low-Dose Radiation Therapy
- (no location specified)
Jan 22, 2023
Tofatib Treatment for IgG4-related Disease
Recruiting
- IgG4-related Disease
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Nov 15, 2022
Takayasu Arteritis Trial in China (MMF, CYC, Glucocorticoids)
Active, not recruiting
- Takayasu Arteritis
- MMF
- +4 more
-
Shijiazhuang, Hebei, China
- +6 more
Feb 26, 2022
Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)
Recruiting
- Sjogren's Syndrome
- Placebo
- +2 more
-
Anniston, Alabama
- +77 more
Aug 18, 2022
Ulcerative Colitis Trial in Worldwide (Cobitolimod 250 mg, Cobitolimod 500 mg, Placebo)
Recruiting
- Ulcerative Colitis
- Cobitolimod 250 mg
- +2 more
-
Naples, Florida
- +24 more
Aug 1, 2022
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)
Terminated
- Uveitis
- +3 more
- intravitreal injection of Conbercept
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (PUMCH)
Oct 24, 2022
Inflammatory Response, Weakness, Muscle Trial (Methylprednisolone, NaCl 0.9%)
Recruiting
- Inflammatory Response
- Weakness, Muscle
- Methylprednisolone
- NaCl 0.9%
-
Genk, BelgiumZiekenhuis Oost-Limburg
Jan 25, 2023
Pulmonary Disease, Chronic Obstructive, Pneumonia, Bacterial Trial in Ann Arbor (Bronchoscopy with bilateral bronchoalveolar
Completed
- Pulmonary Disease, Chronic Obstructive
- Pneumonia, Bacterial
- Bronchoscopy with bilateral bronchoalveolar lavages
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System
Apr 26, 2022
Asthma, Cough Variant Asthma Trial in Warsaw (Budesonid or budesonide/fomoterol administered by DPI, Budesonid or
Recruiting
- Asthma
- Cough Variant Asthma
- Budesonid or budesonide/fomoterol administered by DPI
- Budesonid or budesonide/fomoterol administered by MDI
-
Warsaw, PolandDepartment of Internal Medicine, Pneumonology and Allergology, M
Jul 7, 2021
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)
Recruiting
- Idiopathic Thrombocytopenic Purpura
- GNR-069
- Nplate
-
Irkutsk, Irkutsk Region, Russian Federation
- +17 more
Aug 3, 2022
Obesity Trial in Samara (Determination of the level of interleukins in the blood, stool analysis for the intestinal microbiome,
Enrolling by invitation
- Obesity
- Determination of the level of interleukins in the blood, stool analysis for the intestinal microbiome, general clinical tests, glucose tolerance test, hormonal profile
-
Samara, Samara Region, Russian FederationSamara State Medical University
Jun 17, 2023
Atopic Dermatitis Trial in Moscow (Pimecrolimus cream 1%, cream 0.1% methylprednisolone aceponate)
Completed
- Atopic Dermatitis
- Pimecrolimus cream 1%
- cream 0.1% methylprednisolone aceponate
-
Moscow, Russian FederationNational Medical Research Center for Children's Health
May 25, 2021
Hypocalcemia, Vitamin D Deficiency, Postoperative Complications Trial in Lódz (drug, diagnostic test, procedure, other)
Recruiting
- Hypocalcemia
- +6 more
- Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).
- +14 more
-
Łódź, Łódzkie, PolandDepartment of General and Oncological Surgery, Medical Universit
Feb 5, 2022
IBD, Dexamethasone, Postoperative Ileus Trial in Nanjing (Dexamethasone, Normal saline)
Completed
- Inflammatory Bowel Diseases
- +3 more
- Dexamethasone
- Normal saline
-
Nanjing, Jiangsu, ChinaDepartment of Generay Surgery, Jinling hosptal, Medical School o
Feb 8, 2021